Evaluation of the resistance of a geopolymer-based drug delivery system to tampering.

Tamper-resistance is an important property of controlled-release formulations of opioid drugs. Tamper-resistant formulations aim to increase the degree of effort required to override the controlled release of the drug molecules from extended-release formulations for the purpose of non-medical use. In this study, the resistance of a geopolymer-based formulation to tampering was evaluated by comparing it with a commercial controlled-release tablet using several methods commonly used by drug abusers. Because of its high compressive strength and resistance to heat, much more effort and time was required to extract the drug from the geopolymer-based formulation. Moreover, in the drug-release test, the geopolymer-based formulation maintained its controlled-release characteristics after milling, while the drug was released immediately from the milled commercial tablets, potentially resulting in dose dumping. Although the tampering methods used in this study does not cover all methods that abuser could access, the results obtained by the described methods showed that the geopolymer matrix increased the degree of effort required to override the controlled release of the drug, suggesting that the formulation has improved resistance to some common drug-abuse tampering methods. The geopolymer matrix has the potential to make the opioid product less accessible and attractive to non-medical users.

[1]  P. Costa,et al.  Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  E. Sellers,et al.  Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation. , 2009, International journal of pharmaceutics.

[3]  R. Mansbach,et al.  Formulation considerations for the development of medications with abuse potential. , 2006, Drug and alcohol dependence.

[4]  H. Engqvist,et al.  Synthetic Geopolymers for Controlled Delivery of Oxycodone: Adjustable and Nanostructured Porosity Enables Tunable and Sustained Drug Release , 2011, PloS one.

[5]  H. Omidian,et al.  Current approaches in tamper-resistant and abuse-deterrent formulations , 2013, Drug development and industrial pharmacy.

[6]  J. Davidovits,et al.  MAS-NMR studies of geopolymers heat-treated for applications in biomaterials field , 2007 .

[7]  L. Webster,et al.  Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain. , 2011, Journal of opioid management.

[8]  E. Kalso.  Proceedings of the Symposium “Updates of the Clinical Pharmacology of Opioids with Special Attention to Long-Acting Drugs”Oxycodone , 2005 .

[9]  E. Galia,et al.  Opioid extended-release tablets with improved tamper-resistant properties , 2012, Expert opinion on drug delivery.

[10]  A. Basit,et al.  Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol. , 2008, International journal of pharmaceutics.

[11]  Laxmaiah Manchikanti,et al.  Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. , 2008, Pain physician.

[12]  M. Strømme,et al.  Influence of drug distribution and solubility on release from geopolymer pellets--a finite element method study. , 2012, Journal of pharmaceutical sciences.

[13]  H. Engqvist,et al.  Mechanically strong geopolymers offer new possibilities in treatment of chronic pain. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Nathaniel Katz,et al.  Tampering with Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions , 2011, The American journal of drug and alcohol abuse.

[15]  S. Schnoll,et al.  Prescription opioid abuse among enrollees into methadone maintenance treatment. , 2007, Drug and alcohol dependence.

[16]  M. Strømme,et al.  Modeling structure-function relationships for diffusive drug transport in inert porous geopolymer matrices. , 2011, Journal of pharmaceutical sciences.

[17]  R. Barkin,et al.  Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. , 2012, Mayo Clinic proceedings.

[18]  Y. Chien,et al.  In-vitro transdermal permeation of oxycodone: (I) effect of PH, delipidization and skin stripping , 1989 .

[19]  B. Kuehn.  Opioid Prescriptions Soar , 2007 .

[20]  Juergen Siepmann,et al.  Modeling of diffusion controlled drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.